NMDA receptors interact with the retrieval memory enhancing effect of pioglitazone in mice

Pharmacology Biochemistry and Behavior

Volumn 126, Issue , 2014, Pages 136-145

  Almasi Nasrabadi, Mina ^a   Gharedaghi, Mohammad Hadi ^a   Rezazadeh, Parisa ^a   Dehpour, Ahmad Reza ^a   Javadi Paydar, Mehrak ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Glutamatergic pathway; Memory; MK 801; NMDA; Pioglitazone; Scopolamine

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PIOGLITAZONE; SCOPOLAMINE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; DIZOCILPINE MALEATE; N METHYLASPARTIC ACID; SCOPOLAMINE BROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; DRUG RECEPTOR BINDING; INFORMATION RETRIEVAL; MALE; MEMORY; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NONHUMAN; RECOGNITION; SHORT TERM MEMORY; SPATIAL MEMORY; Y-MAZE TEST; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; MAZE TEST; METABOLISM; RECALL;

ANIMALS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; MENTAL RECALL; MICE; N-METHYLASPARTATE; RECEPTORS, N-METHYL-D-ASPARTATE; SCOPOLAMINE HYDROBROMIDE; THIAZOLIDINEDIONES;

EID: 84908000641     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.09.019     Document Type: Article

References (48)

1. T. Abel, and K.M. Lattal Molecular mechanisms of memory acquisition, consolidation and retrieval Neurobiology 11 2001 180 187
2. M. Allahtavakoli, A. Shabanzadeh, A. Roohbakhsh, and A. Pourshanazari Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats Basic Clin Pharmacol Toxicol 101 2007 309 314
3. N. Allami, M. Javadi-Paydar, F. Rayatnia, K. Sehhat, R. Rahimian, and A. Norouzi Suppression of nitric oxide synthesis by l-NAME reverses the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice Eur J Pharmacol 650 2011 240 248
4. M. Almasi-Nasrabadi, M. Javadi-Paydar, S. Mahdavian, R. Babaei, M. Sharifian, and A. Dehpour Involvement of NMDA receptors in the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice Behav Brain Res 231 1 2012 138 145
5. P. Aoun, J.W. Simpkins, and N. Agarwal Role of PPAR-ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells Invest Ophthalmol Vis Sci 44 2003 2999 3004
6. JrD Bartholomew-Hodges, M.D. Lindner, J.B. Hogan, K.M. Jones, and E.J. Markus Scopolamine induced deficits in a battery of rat cognitive tests: comparisons of sensitivity and specificity Behav Pharmacol 20 2009 237 251
7. G.J. Biessels, S. Staekenborg, E. Brunner, C. Brayne, and P. Scheltens Risk of dementia in diabetes mellitus: a systematic review Lancet Neurol 5 2006 64 74
8. E.M. Blalock, J.T. Phelps, T. Pancani, J.L. Searcy, K.L. Anderson, and J.C. Gant Effects of long-term pioglitazone treatment on peripheral and central markers of aging PLoS ONE 5 4 2010 e10405
9. O. Braissant, F. Foufelle, C. Scotto, M. Dauca, and W. Wahli Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat Endocrinology 137 1996 354 366
10. 2 + disruption in Alzheimer's disease by presenilin regulation of InsP(3) receptor channel gating Neuron 58 2008 871 883
11. F. Dellu, W. Mayo, J. Cherkaoui, M. Le Moal, and H. Simon A two-trial memory task with automated recording: study in young and aged rats Brain Res 588 1992 132 139
12. G. Ellison The N-methyl-d-aspartate antagonists phencylidine, ketamine and dizolcipine as both behavioral and anatomical models of dementia Brain Res Rev 20 1995 140 267
13. R. Etcheberrigaray, N. Hirashima, L. Nee, J. Prince, S. Govoni, and M. Racchi Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families Neurobiol Dis 5 1998 37 45
14. C. Feillet-Coudray, E. Rock, C. Coudray, K. Grzelkowska, V. Azais-Braesco, and D. Dardevet Lipid peroxidation and antioxidant status in experimental diabetes Clin Chim Acta 284 1999 31 43
15. T. Fujiwara, A. Okuno, S. Yoshioka, and H. Horikoshi Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and C57BL/KsJ-db/db mice Metabolism 44 1995 486 490
16. X. Gonda Basic pharmacology of NMDA receptors Curr Pharm Des 18 12 2012 1558 1567
17. R. Gupta, and L.K. Gupta Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer's disease Pharmacol Biochem Behav 102 2 2012 184 190
18. H. Hanyu, T. Sato, A. Kiuchi, H. Sakurai, and T. Iwamoto Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus J Am Geriatr Soc 57 2009 177 179
19. M.T. Heneka, M. Sastre, L. Dumitrescu-Ozimek, A. Hanke, I. Dewachter, and C. Kuiperi Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice Brain 128 2005 1442 1453
20. Z. Hlinak, and I. Krejci Concurrent administration of subeffective doses of scopolamine and MK-801 produces a short-term amnesia for the elevated plus-maze in mice Behav Brain Res 91 1998 83 89
21. R.L. Hunter, D.Y. Choi, S.A. Ross, and G. Bing Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley rats Neurosci Lett 432 2008 198 201
22. N.C. Inestrosa, J.A. Godoy, R.A. Quintanilla, C.S. Koenig, and M. Bronfman Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling Exp Cell Res 304 2005 91 104
23. J. Janson, T. Laedtke, J.E. Parisi, P. O'Brien, R.C. Petersen, and P.C. Butler Increased risk of type 2 diabetes in Alzheimer disease Diabetes 53 2004 474 481
24. L.Y. Jiang, S.S. Tang, X.Y. Wang, L.P. Liu, Y. Long, and M. Hu PPARγ agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus CNS Neurosci Ther 18 8 2012 659 666
25. B. Kaur, N. Singh, and Jaggi A. Singh Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia Fundam Clin Pharmacol 23 2009 557 566
26. I. Klinkenberg, and A. Blokland The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies Neurosci Biobehav Rev 2010 1307 1350
27. J. Kornhuber, F. Mack-Burkhardt, M.E. Kornhuber, and P. Riederer MK-801 binding sites in post-mortem human frontal cortex Eur J Pharmacol 162 1989 483 490
28. A. Kumar, M.B. Schapiro, C. Grady, J.V. Haxby, E. Wagner, and J.A. Salerno High-resolution PET studies in Alzheimer's disease Neuropsychopharmacology 4 1 1991 35 46
29. P. Kumar, R.K. Kaundal, S. More, and S.S. Sharma Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease Behav Brain Res 197 2009 398 403
30. G. Landreth PPARgamma agonists as new therapeutic agents for the treatment of Alzheimer's disease Exp Neurol 199 2006 245 248
31. D.J. Loane, B.F. Deighan, R.M. Clarke, R.J. Griffin, A.M. Lynch, and M.A. Lynch Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain Neurobiol Aging 30 2009 920 931
32. S. Moreno, S. Farioli-Vecchioli, and M.P. Ceru Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS Neuroscience 123 2004 131 145
33. G.G. Murphy, V. Shah, J.W. Hell, and A.J. Silva Investigation of age-related cognitive decline using mice as a model system: neurophysiological correlates Am J Geriatr Psychiatry 14 2006 1012 1021
34. 2 + currents by PPAR-γ agonists in cultured hippocampal neurons J Neurochem 109 2009 1800 1811
35. A.R. Pathan, B. Viswanad, S.K. Sonkusare, and P. Ramarao Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced memory impairment in rats Life Sci 79 2006 2209 2216
36. W.A. Pedersen, P.J. McMillan, J.J. Kulstad, J.B. Leverenz, S. Craft, and G.R. Haynatzki Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice Exp Neurol 199 2006 265 273
37. M.E. Risner, A.M. Saunders, J.F. Altman, G.C. Ormandy, and S. Craft Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease Pharmacogenomics J 6 2006 246 254
38. K. Ritchie, and D. Kildea Senile dementia "age-related" or "aging related"? Evidence from meta-analysis of dementia prevalence in the oldest old Lancet 346 1995 931 934
39. M.A. Rogawski AMPA receptors as a molecular target in epilepsy therapy Acta Neurol Scand 127 2013 9 18
40. C. Romera, O. Hurtado, J. Mallolas, M.P. Pereira, J.R. Morales, and A. Romera Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPAR-gamma target gene involved in neuroprotection J Cereb Blood Flow Metab 27 2007 1327 1338
41. C.M. Ryan, M.I. Freed, J.A. Rood, A.R. Cobitz, B.R. Waterhouse, and M.W. Strachan Improving metabolic control leads to better working memory in adults with type 2 diabetes Diabetes Care 29 2006 345 351
42. M. Salehi-Sadaghiani, M. Javadi-Paydar, M.H. Gharedaghi, A. Zandieh, P. Heydarpour, and Y. Yousefzadeh-fard NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice Psychopharmacology 223 2012 345 355
43. E. Steen, B.M. Terry, E.J. Rivera, J.L. Cannon, T.R. Neely, and R. Tavares Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes? J Alzheimers Dis 7 1 2005 63 80
44. S. Uryu, J. Harada, M. Hisamoto, and T. Oda Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons Brain Res 924 2002 229 236
45. F.J. van der Staay, K. Rutten, C. Erb, and A. Blokland Effects of the cognition impairer MK-801 on learning and memory in mice and rats Behav Brain Res 220 1 2011 215 229
46. G.S. Watson, B.A. Cholerton, M.A. Reger, L.D. Baker, S.R. Plymate, and S. Asthana Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study Am J Geriatr Psychiatry 13 2005 950 958
47. Q.Q. Yin, J.J. Pei, S. Xu, D.Z. Lou, S.Q. Dong, and M.H. Sun Pioglitazone improves cognitive function via increasing insulin sensitivity and strengthening antioxidant defense system in fructose-drinking insulin resistance rats PLoS ONE 8 3 2013 e59313
48. X. Zhao, Z. Ou, J.C. Grotta, N. Waxham, and J. Aronowski Peroxisome-proliferator-activated receptor-gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity Brain Res 1073-74 2006 460 469